Rossari Biotech Limited announced significant capacity expansions for its material subsidiaries, Unitop Chemicals Private Limited and Tristar Intermediates Private Limited.
The Board of Directors at Unitop Chemicals approved a capacity expansion of 18,500 MTPA, which they will implement in a phased manner. They expect the project to complete by the fourth quarter of FY 2025-26. An investment of ₹77 crore will fuel the expansion, financing it through a mix of internal accruals and debt. The strategic move aims to support new product lines, meet evolving market demands, and sharpen the company’s competitive advantage in both domestic and export markets.
Tristar Intermediates to Enhance Capacity by 3,600 MTPA
The board of directors of Tristar Intermediates Private Limited also approved a capacity enhancement plan. Currently operating at 90% capacity utilisation of its 15,000 MTPA facility, Tristar will add an additional 3,600 MTPA by Q4 FY 2025-26.
The expansion, requiring an investment of ₹20 Crores, will similarly be financed through internal accruals and debt. It aims to modernise the facility by upgrading existing equipment, enhancing energy efficiency, improving product consistency, boosting process safety, and reducing long-term maintenance costs.
Strengthening Market Leadership
Rossari Biotech has established itself as one of India’s leading manufacturers of textile speciality chemicals. The company operates across three major product categories:
- Home, Personal Care, and Performance Chemicals
- Textile Speciality Chemicals
- Animal Health and Nutrition
Rossari supports its strong innovation capabilities with two R&D centers. One is at its Silvassa manufacturing facility, and the other is at its research lab in IIT Bombay. As reported by dsij.in, these latest expansion initiatives reinforce Rossari Biotech’s commitment to innovation and sustainability. They also strengthen the company’s leadership in the speciality chemicals sector.
